Rob, a 42-year-old fitness enthusiast, started pondering testosterone replacement therapy after seeing social media ads. He was already in good shape and followed a high-protein diet rich in avocado oil. Despite his normal testosterone tests, a private clinic prescribed TRT anyway, and he felt no real need for it.
Rahim, 48, sought an energy and fitness boost at a men’s clinic a decade ago. He received an injection that day, and over time the clinic increased his dosage. He felt little benefit and now says he felt exploited, as if the clinic was profiting from his body.
TRT, available as pills, patches, injections or implants, has become highly visible. It is touted online and in ads as improving mood, energy, sex drive and even physique. The global market is estimated at $1.9 billion. For men with genuinely low testosterone, TRT can lift mood and energy, boost muscle, reduce fat and improve certain heart-health biomarkers. Some studies have shown no link between TRT and prostate cancer, and many clinics monitor patients closely to manage risks.
However, many men receive TRT without clear evidence they need it. Experts warn that increasing testosterone beyond normal levels can cause harm. Side effects include reduced fertility and testicular shrinkage, erythrocytosis, acne and breast tissue swelling. Urologists and endocrinologists urge careful consideration and ongoing monitoring.
Public messaging around testosterone often emphasizes masculine ideals, which can skew perceptions of TRT’s risks and benefits. Not all information online is accurate. Some clinicians warn that social-media content frequently omits testing and side effects.
Testosterone levels exist on a broad range, roughly 300 to 1,000 ng/dl. After about age 40, levels tend to decline by about 1 percent per year, contributing to rising interest in TRT as the population ages. Some data also suggest a drop in average testosterone among younger men, influenced by obesity and diabetes.
Historical context shows how long people have sought hormonal rejuvenation. In the 19th and early 20th centuries, doctors experimented with animal testes or glandular extracts. Modern synthetic testosterone emerged in 1935, but early medical cautions—especially about prostate cancer—limited widespread use for decades. By the 2000s, TRT gained popularity, though regulatory warnings about cardiovascular risks persisted.
The TRAVERSE trial, the largest randomized study of TRT in men with low testosterone, followed more than 5,000 men for about three years. It found no rise in prostate cancer, strokes, heart attacks or cardiovascular deaths among treated men with initially low testosterone. For men with genuinely low testosterone and normal PSA levels, moving into the normal range appears to carry a low cancer and heart-risk profile. Yet debates continue about what should constitute “low” testosterone. Different medical bodies offer varying cutoffs, and testosterone levels can fluctuate daily.
TRT’s impact on mood and energy varies by individual. The TRAVERSE trial showed mood and energy improvements in men with clearly low testosterone, but benefits for mild depressive symptoms were less clear. Some patients report improvements in general well-being, while others see limited cognitive or sleep benefits. Fertility concerns are real; TRT can suppress sperm production, and recovery after stopping TRT can take years. Treatments to help restore fertility can have their own side effects and are not always covered by insurance.
Clinics vary in practice. Some may initiate TRT after a single test, despite guidelines urging at least two tests and baseline monitoring. Ethical clinics emphasize baseline testing, ongoing blood work, and clear discussions about fertility and long-term risks. Concerns persist that some patients may receive high doses or extended therapy without adequate counseling or follow-up.
Emerging questions complicate decisions. Should TRT be paired with lifestyle changes before pharmacological intervention? How should doctors balance TRT with newer weight-management drugs like GLP-1 therapies? And which testosterone metric matters more: total testosterone or free testosterone, the latter potentially better reflecting tissue availability?
For men considering TRT, experts stress tailored assessment. If a clinician recommends TRT, patients should expect a thorough review of risks and benefits, a clear dosing plan, and regular blood tests to monitor testosterone, blood counts and PSA. If fertility is a goal, discuss options to preserve or regain fertility before starting treatment.
Bottom line for readers: Testosterone Replacement Therapy can help men with truly low testosterone, but it is not a universal solution. Some patients experience meaningful improvements in energy and mood, while others see limited benefits and risk side effects. Thorough medical evaluation, transparent discussion of potential outcomes, and careful monitoring are essential.
Related topics
